FMD vaccines

Virus Research

Volumn 91, Issue 1, 2003, Pages 81-99

  Doel, T R ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Animal disease; Foot and mouth disease; Vaccination

Indexed keywords

ANTHRAX VACCINE; BRUCELLA VACCINE; FOOT AND MOUTH DISEASE VACCINE; VIRUS VACCINE;

CATTLE DISEASE; DRUG MANUFACTURE; DRUG SAFETY; ECONOMIC ASPECT; EMERGENCY TREATMENT; FOOT AND MOUTH DISEASE; HISTORY OF MEDICINE; INFECTION CONTROL; LIVESTOCK; NONHUMAN; PRIORITY JOURNAL; REVIEW; VACCINATION; VACCINE PRODUCTION; VIRUS CARRIER; VIRUS IMMUNITY; VIRUS TRANSMISSION;

ANIMALS; CATTLE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; VACCINATION; VIRAL VACCINES;

ANIMALIA; ANTHRAX; BOS TAURUS; BRUCELLA;

EID: 0037235390     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00261-7     Document Type: Review

References (99)

1. Adamowicz Ph., Legrand B., Guerche J., Prunet P. Un nouveau procédé de concentration et de purification de virus. Application au virus de la fièvre aphteuse produit sur cellules BHK21 pour l'obtention de vaccines hautement purifiés. Bull. Off. Int. Epiz. 81:1974;1125-1150.
2. Ahl, R., Haas, B., Lorenz, R.J., Wittmann, G., 1990. Alternative potency test of FMD vaccines and results of comparative antibody assays in different cell systems and ELISA. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease. Lindholm, Denmark, 25-29 June. Food and Agriculture Organisation (FAO), Rome, 51-60.
3. Anderson E.C., Capstick P.B., Mowat G.N., Leech F.B. In vitro method for safety testing of foot-and-mouth disease vaccines. J. Hyg. Camb. 68:1970;159.
4. Anderson E.C., Doughty W.J., Anderson J. The effect of repeated vaccination in an enzootic foot-and-mouth disease area on the incidence of virus carrier cattle. J. Hyg. Camb. 73:1974;229-235.
5. Anon., 1968. 'Épizootiologie Analytique la Contagion Aphteuse' in La Fièvre Aphteuse Spontanée, In: Joubert, L., Mackowiak., C. (Eds.), Fondation Mérieux Expansion Scientifique, vol. II. pp. 237-279.
6. Anon., 1968. Methodes de Prophylaxie' in La Lutte Anti-Aphteuse, In: Joubert, L., Mackowiak, C. (Eds.), Fondation Mérieux Expansion Scientifique, vol. III. pp. 341-450.
7. Anon., 1989. Report from the Commission to the Council on a study carried out by the Commission on policies currently applied by Member States in the control of foot and mouth disease, CEC Brussels, Belgium.
8. Bachrach H.L. Ribonucleic acid of foot and mouth disease virus: its preparation, stability, and plating efficiency on bovine-kidney cultures. Virology. 12:1960;258-271.
9. Bahnemann H.G. The inactivation of foot and mouth disease virus by ethyleneimine and propyleneimine. Zbl. Vet. Med. B. 20:1973;356-360.
10. Barteling, S.J., 1998. The 'truncated' potency test. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Poiana-Brasov, Romania, 23-27 September 1997, Food and Agriculture Organisation (FAO), Rome, 29.
11. Beck E., Strohmaier K. Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J. Virol. 61:1987;1621-1629.
12. Belin M. Première tentative de vaccination antiaphteuse réalisée à l'aide des complexes vaccino-aphteux. C.R. Soc. De Biologie Paris. 96:1927;116.
13. Black L., Francis M.J., Rweyemamu M.M., Umehara O., Boge A. The relationship between serum antibody titres and protection from foot and mouth disease in pigs after oil emulsion vaccination. J. Biol. Stand. 12:1984;379-389.
14. Black L., Nicholls M.J., Rweyemamu M.M., Ferrari R., Zunino M.A. Foot-and-mouth disease vaccination: a multifactorial study of the influence of antigen dose and potentially competitive immunogens on the response of cattle of different ages. Res. Vet. Sci. 40:1986;303-307.
15. Black L., Pay T.W.F. The evaluation of hypersensitivity tests in cattle after foot and mouth disease vaccination. J. Hyg. Camb. 74:1975;169.
16. Brooksby, J.B., Rogers, J., 1957. Methods used in typing the virus of foot-and-mouth disease at Pirbright, 1950-1955. Methods of Typing and Cultivation of Foot-and-Mouth Disease Virus, project 208 of OEEC, Paris, 31-34.
17. Brown F., Crick Joan. Application of agar-gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot and mouth disease. J. Immunol. 82:1959;444-447.
18. Capstick P.B., Telling R.C., Chapman W.G., Stewart D.L. Growth of a cloned strain of hamster kidney cells in suspended cultures and their susceptibility to the virus of foot-and-mouth disease. Nature. 195:(4847):1962;1163-1164.
19. Chang T.S., Chang C.C., Tsai S.S., Chang G.N., Kuo M., Chung W.B. An outbreak of foot and mouth disease in pigs in southern Taiwan. J. Chin. Soc. Vet. Sci. 23:1997;269-273.
20. Chen B.-J., Sung W.H.T., Shieh H.K. Managing an animal health emergency in Taipei China: foot and mouth disease. Rev. Sci. Tech. Off. Int. Epiz. 18:1999;186-192.
21. Cox S.J., Barnett P.V., Dani P., Salt J.S. Emergency vaccination of sheep against foot and mouth disease: protection against disease and reduction in contact transmission. Vaccine. 17:1999;1858-1868.
22. Cunliffe H.R. Observations on the duration of immunity in cattle after experimental infection with foot-and-mouth disease. Cornell Veterinarian. 54:1964;501-510.
23. Cunliffe H.R., Graves J.H. Formalin-treated foot and mouth disease virus: comparison of two adjuvants in cattle. Can. J. Comp. Med. 27:1963;193-197.
24. de Clercq, K., Koenen, F., Strobbe, R., Debecq, J., 1988. Simultaneous vaccination of pigs against foot-and-mouth disease and classical swine fever. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Prague, Czechoslovakia, 20-23 September. Food and Agriculture Organisation (FAO), Rome, pp. 56-62.
25. de Leeuw P.W., Tiessink J.W.A., Van Bekkum J.G. The challenge of vaccinated pigs with foot and mouth disease virus. Zbl. Vet. Med. B. 26:1979;85-97.
26. Doel T.R., Chong W.K.T. Comparative immunogenicity of 146s, 75s, and 12s particles of FMDV. Arch. Virol. 73:1982;185-191.
27. Doel, T.R., Fletton, B.W., Staple, R.F., 1982. Further developments in the quantification of small RNA viruses by u.v. photometry by sucrose density gradients. Joint ESACT/IABS Meeting on the Use of Heteroploid and Other Cell Substrates for the Production of Biologicals, Heidelberg 1981, Basel: S. Karger, Dev. Biol. Standard. 50, 209-219.
28. Doel T.R., Pullen L. International bank for foot-and-mouth disease vaccine: stability studies with virus concentrates and vaccines prepared from them. Vaccine. 8:1990;473-478.
29. Doel T.R., Williams L., Barnett P.V. Emergency vaccination against foot-and-mouth disease: the rate of development of immunity and its implications for the carrier state. Vaccine. 12:1994;592-600.
30. Doel, T.R., Lombard, M., Fawthrop, D., Schermbrucker, C., Dubourget, P., 1998. Testing Of FMD Vaccines. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Aldershot, United Kingdom, 14-18 September, 1998. Food and Agriculture Organisation (FAO), Rome.
31. Donaldson, A.I., 2000. The role of sheep in the epidemiology of foot and mouth disease and proposals for control and eradication in animal populations with a high density of sheep. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Borovets, Bulgaria, 5-8 September. Food and Agriculture Organisation (FAO), Rome, pp. 107-116.
32. Donaldson, A.I., Have, P., 1997. Criteria to consider and operational requirements for implementing emergency (ring) vaccination. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Kibbutz Ma'ale Hachamisha, Israel, 2-6 September, 1996. Food and Agriculture Organisation (FAO), Rome, pp. 201-207.
33. Donaldson A.I., Doel T.R. Foot-and-mouth disease: the risk for Great Britain after 1992. Vet. Rec. 131:1992;114-120.
34. Donaldson A.I., Kitching R.P. Transmission of foot-and-mouth disease by vaccinated cattle following natural challenge. Res. Vet. Sci. 46:1989;9-14.
35. Dubourget, P., Detraz, N., Stellman, C., Tixier, G., Lombard, M., 1987. Prophylaxis of foot and mouth disease: influence of annual booster vaccination on the level and specificity of neutralizing antibodies. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Lyons, France, 22-25 September. Food and Agriculture Organisation (FAO), Rome, pp. 37-43.
36. Dunn C.S., Donaldson A.I. Natural adaption to pigs of a Taiwanese isolate of foot and mouth disease virus. Vet. Rec. 141:1997;174-175.
37. Espinet R.G. Nuevo tipo de vacuna antiaftosa: a complejo glucovirico. Gac. Vet. (B. Aires). 13:(74):1951;265-277.
38. European Pharmacopoeia, 1993. Vaccinum Aptharum Epizooticarum Inactivatum Ad Ruminantes. European Pharmacopoeia (Veterinary) Monograph 63. Maisonneuve, Saint Ruffine, France.
39. Fayet M.T., Fargeaud D., Louisot P., Stellman C., Roumiantzeff M. Mesure physico-chimique des particules 140S du virus de la fièvre aphteuse. Ann. Inst. Pasteur. 121:1971;107-118.
40. Ferris N.P., Donaldson A.I. The World Reference Laboratory for foot and mouth disease: a review of 33 years of activity (1958-1991). Rev. Sci. Tech. Off. Int. Epiz. 11:1992;657-684.
41. Fish R.C., Van Bekkum J.G., Lehmann R.P., Richardson G.V. Immunologic responses in Dutch cattle vaccinated with foot-and-mouth disease vaccines under field conditions: neutralizing antibody responses to O, A and C types. Am. J. Vet. Res. 30:1969;2115-2123.
42. Fontaine J. Vaccination and prophylaxis of foot and mouth disease in France and Europe. Sci. Vet. Med. Comp. 87:1985;47-66.
43. Fracastorius, H., 1546. De sympathia et antipathia rerum liber unus. De contagione et contagiosis morbis et eorum curatione liber I, Venice, Heirs of L.A. Junta.
44. Francis M.J., Black L. Antibody response in pig nasal fluid and serum following foot and mouth disease infection or vaccination. J. Hyg. Camb. 91:1983;329-334.
45. Francis M.J., Ouldridge E.J., Black L. Antibody response in bovine pharyngeal fluid following foot and mouth disease vaccination and, or, exposure to live virus. Res. Vet. Sci. 35:1983;206-210.
46. Frenkel H.S. La culture du virus de la fièvre aphteuse sur l'épithélium de la langue des bovidés. Bull. Off. Int. Epiz. 28:1947;155-162.
47. Freund J. The mode of action of immunologic adjuvants. Adv. Tuberc. Res. 7:1956;130-148.
48. Galloway I.A., Henderson W.M., Brooksby J.B. Strains of the virus of foot-and-mouth disease recovered from outbreaks in Mexico. Proc. Soc. Exp. Biol. Med. 69:1948;57-84.
49. Garland, A.J.M., 1997. The availability of foot and mouth disease vaccine for emergency vaccination in Europe. Thirty Second Meeting of the European Commission for the Control of Foot and Mouth Disease, Rome, Italy, 2-4 April. Food and Agriculture Organisation (FAO), Rome.
50. Geering W.A. Foot and mouth disease in sheep. Aust. Vet. J. 43:1967;485-489.
51. Hedger R.S. Observations on the carrier state and related antibody titres during an outbreak of foot-and-mouth disease. J. Hyg. Camb. 68:1970;53-60.
52. Hedger R.S., Condy J.B. Transmission of foot-and-mouth disease from African buffalo virus carriers to bovines. Vet. Rec. 117:1985;205.
53. Hedger R.S., Condy J.B., Gradwell D.V. The response of some African wildlife species to foot and mouth disease vaccination. J. Wildl. Dis. 16:1980;431-438.
54. Hedger R.S., Taylor W.P., Barnett I.T.R., Reik R., Harpham D. Simultaneous vaccination of cattle against foot and mouth disease and rinderpest. Trop. Anim. Health Prod. 18:1986;21-25.
55. Henderson W.M., Galloway I.A. The use of culture virus in the preparation of foot and mouth disease vaccine. J. Hyg. Camb. 51:(4):1953;546-558.
56. Hugh-Jones, M.E., 1979. Some effects of foot and mouth disease in Brasilian cattle. Paper presented at the Second International Symposium on Veterinary Epidemiology and Economics, Canberra, Australia.
57. James A.D., Ellis P.R. Benefit-cost analysis in foot and mouth disease control programmes. Br. Vet. J. 134:1978;47-52.
58. Jerábek, J., Drábek, J., Flachsel, P., Hubik, R., Dedek, L., 1988. Influence of vaccines against swine fever, erysipelas and parvovirosis on the immune response in FMD vaccination of pigs. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Prague, Czechoslovakia, 20-23 September. Food and Agriculture Organisation (FAO), Rome, pp. 65-67.
59. Joseph P.G., Hedger R.S. Serological response of cattle to simultaneous vaccinations against foot and mouth disease and haemorrhagic septicaemia. Vet. Rec. 114:1984;494-496.
60. Kitching, R.P., 1997. Vaccination of calves against FMD in the presence of maternally derived antibody. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Kibbutz Ma'ale Hachamisha, Israel, 2-6 September, 1996. Food and Agriculture Organisation (FAO), Rome, pp. 191-195.
61. Kitching R.P., Salt J.S. The interference by maternally-derived antibody with active immunization of farm animals against foot and mouth disease. Br. Vet. J. 151:1995;379-389.
62. Laporte J., Grosclaude J., Wantyghem J., Bernard S., Rouze P. Neutralisation en culture cellulaire du pouvoir infectieux du virus de la fièvre aphteuse par des sérums provenant de porcs immunisés à l'aide d'une protéine virale purifée. C.R. Acad. Sci. Paris. 276:1973;3399-3401.
63. Leforban, Y., 1997. Situation of FMD in Europe and in other regions in 1996. In: Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Kibbutz Ma'ale Hachamisha, Israel, 2-6 September, 1996. Food and Agriculture Organisation (FAO), Rome, pp. 23-29.
64. Leunen J. Application of the colour test for the study of foot-and-mouth disease virus. Bull. Off. Int. Epiz. 51:1959;409-416.
65. Löffler F., Frosch P. Summarischer Bericht über die Ergebnisse der Untersuchungen der Kommission zur Erforschung der Maul- und Klauenseuche bei dem Institut für Infektionskrankheiten in Berlin. Cent. Bakt., Parasit. Infekt. 22:(10/11):1897;257-259.
66. Lombard, M.F., Shermbrucker, C.G., 1994. Vaccines for control of foot-and-mouth disease worldwide: production, selection and field performance. Diagnosis and Epidemiology of Foot-and-Mouth Disease in Southeast Asia, Proceedings of an international workshop held at Lampang, Thailand, September 6-9, 1993. ACIAR Proceedings No. 51, 16-20.
67. MacPherson I.A., Stoker M.G.P. Polyoma transformation of hamster cell clones-an investigation of genetic factors affecting cell competence. Virology. 16:1962;147-151.
68. Manual of Standards for Diagnostic Tests and Vaccines (2000). Chapter 2.1 Foot and Mouth Disease. Office International des Epizooties, Paris.
69. Martin W.B., Chapman W.G. The tissue culture colour test for assaying the virus and neutralizing antibody of foot-and-mouth disease and its application to the measurement of immunity in cattle. Res. Vet. Sci. 2:1961;53-61.
70. McKercher P.D., Giordano A.R. Foot-and-mouth disease in swine. I. The immune response of swine to chemically-treated and non-treated foot-and-mouth disease virus. Arch. Ges. Virusforsch. 20:(1):1967;39-53.
71. McVicar J.W., Sutmoller P. The epizootiological importance of foot and mouth disease carriers. Arch. Ges. Virusforsch. 26:1969;217-224.
72. Medicines Control Agency, 1997. Rules and guidance for pharmaceutical manufacturers and distributors. The Stationery Office, London.
73. Michelsen E. Experiences on vaccination of pigs. Arch. Exp. Vet. Med. 15:1961;317-321.
74. Morrow A.W., Whittle C.J., Eales W.A. A comparison of methods for the concentration of foot-and-mouth disease virus for vaccine preparation. Bull. Off. Int. Epiz. 81:1974;1155-1167.
75. Mowat G.N., Chapman W.G. Growth of foot and mouth disease virus in a fibroblastic cell line derived from hamster kidneys. Nature. 194:1962;253-255.
76. Mussgay M. Über den Mechanismus der pH-Inaktivierung des Virus der Maul-und Klauenseuche. Monatsh. Tierheilk. 11:1959;185-190.
77. Nicholls M.J., Black L., Rweyemanu M.M., Gradwell D.V. Effect of age on response of cattle to vaccination against foot-and-mouth disease. Br. Vet. J. 141:1985;17-26.
78. Power A.P., Harris S.A. A cost-benefit evaluation of alternative control policies for foot and mouth disease in Great Britain. J. Agric. Econ. 24:1973;573-596.
79. Remond, M., Cruciere, C., Kaiser, C., Lebreton, F., Moutou, F., 1998. Preliminary results of a serological survey for residual foot and mouth disease antibodies in French cattle 6 years after the end of vaccination. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Poiana-Brasov, Romania, 23-27 September, 1997, Food and Agriculture Organisation (FAO), Rome, pp. 84-86.
80. Report of the Committee of Inquiry on Foot-and-Mouth Disease 1968. The Northumberland Report. Part One, Her Majesty's Stationery Office, London, 1969.
81. Rweyemamu M.M. The selection of vaccine strains of foot and mouth disease. Br. Vet. J. 134:1978;63-67.
82. Rweyemamu, M.M., Black, L., Nicholls, M.J., Basarab, O., O'Reilly, K.J., 1982. The response of cattle to FMD vaccination. In: Proceeding, 16th Conference, Foot and Mouth Disease, vol. 1, 14-17 September, Office International des Epizooties, pp. 383-393.
83. Salt J.S., Barnett P.V., Dani P., Williams L. Emergency vaccination of pigs against foot and mouth disease: protection against disease and reduction in contact transmission. Vaccine. 16:1998;746-754.
84. Salt, J.S., Williams, L., Statham, R. Barnett, P.V., 1995. Further studies on the rate of development of protection in cattle given emergency vaccination against FMD. In: Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Vienna, Austria, 19-22 September, 1994. Food and Agriculture Organisation (FAO), Rome, pp. 90-97.
85. Samuel A.R., Knowles N.J. Foot and mouth disease type O viruses exhibit genetically and geographically distinct evolutionary lineages (topotypes). J. Gen. Virol. 82:2001;609-621.
86. Sellers R.F., Herniman K.A.J. Early protection of pigs against foot-and-mouth disease. Br.Vet.J. 130:1974;440-445.
87. Singh B.S. The carrier state in cattle in foot and mouth disease. N.Z. Vet. J. 17:1969;173-177.
88. Stougaard E. Combating foot and mouth disease in Denmark: economic consequences of various control methods. Rev. Sci. Tech. Off. Int. Epiz. 4:1985;201-205.
89. Telling R.C., Elsworth R. Submerged culture of hamster kidney cells in a stainless steel vessel. Biotechnol. Bioeng. 7:1965;417-434.
90. Terpstra, C., Dekker, A., 1997. Tolerance and efficacy of FMD-double oil emulsion vaccine in 2-week-old calves, lambs and piglets free from maternal antibodies. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Kibbutz Ma'ale Hachamisha, Israel, 2-6 September, 1996. Food and Agriculture Organisation (FAO), Rome, pp. 183-190.
91. Vallée H., Carré H. Sur la pluralité des virus aphteux. C.R. Acad. Sci. Paris. 174:1922;1498-1500.
92. Van Bekkum J.G., Bool P.H., Vermeulen C.J. Experience with the vaccination of pigs for the control of foot and mouth disease in the Netherlands. Tijdschr. Diergeneesk. 92:1967;87-97.
93. van Bekkum J.G., Frenkel H.S., Fredericks H.H.J., Frenkel S. Observations on the carrier state of cattle exposed to foot and mouth disease virus. Tijdschr. Diergeneesk. 84:1959;1159-1164.
94. Vianna Filho Y.L., Astudillo V., Gomes L., Fernandez G., Rozas C.E.E., Ravison J.A., Alonso A. Potency control of foot and mouth disease vaccine in cattle. Comparison of the 50% protective dose and the protection against generalization. Vaccine. 11:1993;1424-1428.
95. Vosloo W., Knowles N.J., Thomson G.R. Genetic relationships between southern African SAT-2 isolates of foot-and-mouth-disease virus. Epidemiol. Infect. 109:1992;547-558.
96. Waldmann O., Köbe K., Pyl G. Die aktive Immunisierung des Rindes gegen Maul-und Klauenseuche mittels Formolimpfstoff. Zent. Bakt. Parasit. Infekt. 138:1937;401-412.
97. Waldmann O., Trautwein K. Experimentelle Untersuchungen über die Pluralität des Maul-und Klauenseuchevirus. Berl. Tierärztl. Wschr. 42:(35):1926;569-571.
98. Wild T.F., Brown F. Nature of the inactivating action of trypsin on foot and mouth disease virus. J. Gen. Virol. 1:1967;247-250.
99. Wittman, G., 1990. The virus carrier state in foot-and-mouth disease. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Lindholm, Denmark, 25-29 June. Food and Agriculture Organisation (FAO), Rome, pp. 15-24.